Answers are grounded in this paper and cite their sources.
Background and Objectives: There is a need to accurately determine long-term prognosis without exposing the vulnerable pediatric population to excess radiation. Their development and care plan may be impacted by traumatic brain injury (TBI) and further impeded by complications and side effects related to conventional imaging or obtaining other prognostic indicators. Biomarkers present an alternative means of determining TBI prognosis. This review seeks to compare contemporary findings regarding these biomarkers to determine which is optimal for pediatric TBI prognosis and predicting long-term outcomes. Materials and Methods: Literature pertaining to pediatric traumatic brain injury was obtained from the PubMed database within the date range of 2010-2026 on August 5th, 2026, and examined to identify validated, accurate, sensitive and specific biomarkers for long-term outcomes. Reports were excluded on the basis of their relevance to the study (i.e., articles pertaining to non-human patients or non-pediatric or non-TBI patients only, or which did not address prognosis or long-term outcomes) and accessibility (available English-language or English-translated manuscripts). Results: Ultimately, 56 qualifying reports were collected, with 14 among those identified providing sensitivity and specificity information, while the remaining 42 elucidated the roles of each biomarker. Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) (included in 2 reports pertaining to specificity, sensitivity, and predictive accuracy), interleukin 5 (IL-5) (included in 1 report), S100 calcium-binding protein B (S100B) (included in 1 report), and glial fibrillary acidic protein (GFAP) (included in 4 reports) were found to have the highest AUCs with coinciding high sensitivity and specificity, indicating that these biomarkers may have good predictive performance. Conclusions: Still, reduced sample sizes and a lack of uniformity in value reporting and in analytical approaches impeded comparisons between each of the biomarkers, signaling that future research should look to standardize approaches, provide more thorough values, and potentially compile multiple biomarkers into a single test-panel to yield the most accurate long-term prognosis for the pediatric TBI cohort.
No takes yet. Share an insight, caveat, or question.
Fracasso et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: